Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Pharmaceutical Research|April 7, 2022
A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid OverdoseTair Lapidot, Mohammed Bouhajib, Janice Faulknor, et al.Journal of Neuromuscular Diseases|June 10, 2017
Analysis of Azithromycin Monohydrate as a Single or a Combinatorial Therapy in a Mouse Model of Severe Spinal Muscular AtrophyErkan Y Osman, Charles W Washington, Madeline E Simon, et al.The Journal of Allergy and Clinical Immunology. Global|June 11, 2025
First-in-class intranasal epinephrine spray for anaphylaxis: Dose finding clinical studyTair Lapidot, Yuval Tal, Dalia Megiddo, et al.The Journal of Clinical Psychiatry|January 8, 2013
A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorderIris Manor, Rachel Ben-Hayun, Judith Aharon-Peretz, et al.The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2023
Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for AnaphylaxisYuval Tal, Yaarit Ribak, Limor Rubin, et al.Pageof 1